Human Intestinal Transporter Database: QSAR Modeling and Virtual Profiling of Drug Uptake, Efflux and Interactions

[1]  Hai Yang,et al.  ACM Transactions on Intelligent Systems and Technology - Special Section on Urban Computing , 2014 .

[2]  F. Van Bambeke,et al.  ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions. , 2011, Current drug targets.

[3]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[4]  Tudor I. Oprea,et al.  A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. , 2011, Journal of medicinal chemistry.

[5]  Michael Wiese,et al.  Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP). , 2011, Bioorganic & medicinal chemistry.

[6]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[7]  G. Szakács,et al.  Understanding transport through pharmacological barriers — are we there yet? , 2010, Nature Reviews Drug Discovery.

[8]  Alexander Tropsha,et al.  Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..

[9]  Alexander Tropsha,et al.  Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.

[10]  Alexander D. MacKerell,et al.  Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter. , 2010, Journal of medicinal chemistry.

[11]  Ligong Chen,et al.  Pharmacogenomics of membrane transporters: past, present and future. , 2010, Pharmacogenomics.

[12]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[13]  X. Ming,et al.  Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil. , 2010, Biochemical pharmacology.

[14]  Sean Ekins,et al.  Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter. , 2009, Molecular pharmaceutics.

[15]  Marilyn E. Morris,et al.  Structure–Activity Relationships and Quantitative Structure–Activity Relationships for Breast Cancer Resistance Protein (ABCG2) , 2009, The AAPS Journal.

[16]  Leslie Z. Benet,et al.  The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs , 2009, Pharmaceutical Research.

[17]  Ulf Norinder,et al.  Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs , 2009, Pharmaceutical Research.

[18]  Andreas Maunz,et al.  Development of decision tree models for substrates, inhibitors, and inducers of p-glycoprotein. , 2009, Current drug metabolism.

[19]  Hui Zhang,et al.  Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[20]  Charles Elkan,et al.  The Transporter Classification Database: recent advances , 2008, Nucleic Acids Res..

[21]  Li Di,et al.  Permeability--in vitro assays for assessing drug transporter activity. , 2008, Current drug metabolism.

[22]  Christel A. S. Bergström,et al.  Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. , 2008, Journal of medicinal chemistry.

[23]  N. Tawari,et al.  Pharmacophore mapping of a series of pyrrolopyrimidines, indolopyrimidines and their congeners as multidrug-resistance-associated protein (MRP1) modulators , 2008, Journal of molecular modeling.

[24]  Christel A. S. Bergström,et al.  Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). , 2008, Journal of medicinal chemistry.

[25]  Lars Olsen,et al.  QSAR Models for the Human H+/Peptide Symporter, hPEPT1: Affinity Prediction Using Alignment-Independent Descriptors , 2008, J. Chem. Inf. Model..

[26]  Alexander Golbraikh,et al.  Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.

[27]  Ulf Norinder,et al.  A Global Drug Inhibition Pattern for the Human ATP-Binding Cassette Transporter Breast Cancer Resistance Protein (ABCG2) , 2007, Journal of Pharmacology and Experimental Therapeutics.

[28]  Gerta Rücker,et al.  y-Randomization and Its Variants in QSPR/QSAR , 2007, J. Chem. Inf. Model..

[29]  W. Haefeli,et al.  Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors , 2007, Drug Metabolism and Disposition.

[30]  Jurre J. Kamphorst,et al.  A performance evaluation of multiple classification models of human PEPT1 inhibitors and non‐inhibitors , 2007 .

[31]  Ian T. Paulsen,et al.  TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels , 2006, Nucleic Acids Res..

[32]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery, 7. Prediction of Oral Absorption by Correlation and Classification , 2007, J. Chem. Inf. Model..

[33]  Sean Ekins,et al.  Pharmacophore-based discovery of ligands for drug transporters. , 2006, Advanced drug delivery reviews.

[34]  Gerald M. Maggiora,et al.  On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..

[35]  B. Vig,et al.  Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding. , 2006, Journal of medicinal chemistry.

[36]  Peter W Swaan,et al.  Computational approaches to modeling drug transporters. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  Miguel A. Cabrera,et al.  A topological substructural approach for the prediction of P-glycoprotein substrates. , 2006, Journal of pharmaceutical sciences.

[38]  A. Ross,et al.  Monocarboxylate transporter MCT1 is a target for immunosuppression , 2005, Nature chemical biology.

[39]  B. Lum,et al.  Quantitative structure-activity relationships of methotrexate and methotrexate analogues transported by the rat multispecific resistance-associated protein 2 (rMrp2). , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[40]  A. Madan,et al.  Topological model for the prediction of MRP1 inhibitory activity of pyrrolopyrimidines and templates derived from pyrrolopyrimidine. , 2005, Bioorganic & medicinal chemistry letters.

[41]  M. Brandsch,et al.  Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1. , 2005, Journal of medicinal chemistry.

[42]  Ronen Feldman,et al.  The Data Mining and Knowledge Discovery Handbook , 2005 .

[43]  Lior Rokach,et al.  Data Mining And Knowledge Discovery Handbook , 2005 .

[44]  Nitesh V. Chawla,et al.  Data Mining for Imbalanced Datasets: An Overview , 2005, The Data Mining and Knowledge Discovery Handbook.

[45]  N. Ozawa,et al.  Transporter Database, TP-Search: A Web-Accessible Comprehensive Database for Research in Pharmacokinetics of Drugs , 2004, Pharmaceutical Research.

[46]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[47]  Leonard E. Trigg,et al.  Technical Note: Naive Bayes for Regression , 2000, Machine Learning.

[48]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[49]  Alexander Golbraikh,et al.  Quantitative Structure−Activity Relationship Analysis of Functionalized Amino Acid Anticonvulsant Agents Using k Nearest Neighbor and Simulated Annealing PLS Methods , 2002 .

[50]  J. Polli,et al.  Rational use of in vitro P-glycoprotein assays in drug discovery. , 2001, The Journal of pharmacology and experimental therapeutics.

[51]  Elazer R. Edelman,et al.  Adv. Drug Delivery Rev. , 1997 .